Nerve Growth Factor–Based Peptides and Optic Nerve Protection
In a rabbit glaucoma model (pressure raised by a gel in the eye), researchers injected NGF around the eye (retrobulbar) before damage. Those rabbits...
Oxervate
Deep research and expert guides on maintaining your visual health.
Oxervate
Oxervate is the brand name for a medicine that contains cenegermin, a lab-made human nerve growth factor, and is formulated as eye drops. It was developed to treat severe corneal problems caused by loss of nerve function, where the surface of the eye has trouble healing on its own. Patients put the drops directly into the eye, allowing the active protein to reach the damaged corneal tissue and encourage nerve repair and surface recovery. By rebuilding nerve connections, the treatment helps restore the cornea’s ability to sense and protect itself, which can reduce ulcers and improve vision in some cases. The product is important because it turned a biological discovery into an approved therapy that can prevent further damage and reduce the need for surgery. Like other drugs, Oxervate can cause side effects such as eye pain or irritation, and it is given under medical supervision with a prescribed schedule. Its availability marked a step forward for treating a condition that was previously difficult to manage and offered hope to patients with persistent corneal disease. Because it addresses the underlying nerve problem rather than only treating symptoms, Oxervate can lead to more lasting improvements in eye health.